Literature DB >> 8586518

Serum concentration of iopamidol after retrograde urethrography in male patients with outlet obstructive symptoms.

I Sasagawa1, M Ishigooka, T Tateno, M Tomaru, H Yanai, T Sawamura, T Nakada.   

Abstract

Serum concentration of iopamidol was measured in 29 male patients with outlet obstructive symptoms after retrograde urethrography. Although no patient showed extravasation, serum iopamidol level was detectable in 4 (14%) patients. Since severe adverse effects are considerably reduced with iopamidol, we prefer to use this contrast medium for retrograde urethrography in male patients with outlet obstructive symptoms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8586518     DOI: 10.1007/bf02550081

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  6 in total

1.  Renal clearance of an ionic high-osmolar and a nonionic low-osmolar contrast medium.

Authors:  H S Thomsen; A Vestergaard; S L Nielsen; N Fogh-Andersen; K Golman; S Dorph
Journal:  Invest Radiol       Date:  1991-06       Impact factor: 6.016

2.  Clinical intravenous urography: comparative trial of ioxaglate and iopamidol.

Authors:  C F Loughran
Journal:  Radiology       Date:  1986-11       Impact factor: 11.105

3.  Urethrovascular reflux and its significance in urology.

Authors:  M G Mukerjee; G E Deshon; J A Bruckman; B T Mittemeyer; A A Borski
Journal:  J Urol       Date:  1974-11       Impact factor: 7.450

4.  Retrograde urethrogram: diagnostic aid and hazard.

Authors:  E M Mullin; L J Peterson; D F Paulson
Journal:  J Urol       Date:  1973-10       Impact factor: 7.450

Review 5.  The new low-osmolar contrast media: a simple guide.

Authors:  P Dawson; R G Grainger; J Pitfield
Journal:  Clin Radiol       Date:  1983-03       Impact factor: 2.350

6.  Evaluation of lopamidol and diatrizoate in excretory urography: a double-blind clinical study.

Authors:  S T Cochran; J W Ballard; R W Katzberg; Z L Barbaric; R Spataro; K Iwamoto; J J Lee
Journal:  AJR Am J Roentgenol       Date:  1988-09       Impact factor: 3.959

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.